P15090 (FABP4_HUMAN) Homo sapiens (Human)
Fatty acid-binding protein, adipocyte UniProtKBInterProSTRINGInteractive Modelling
132 aa; Sequence (Fasta) ;
5 identical sequences: Homo sapiens: E7DVW4; Pan troglodytes: H2QWC5, A0A6D2YBX7; Pan paniscus: A0A2R9APP5; Gorilla gorilla gorilla: G3QWM2
It is possible new templates exist for this target since these models were created.
Available Structures
243 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| Crystal Structure of human FABP4 binding site mutated to that of FABP5 in complex with 5-[[3-(3-cyc… | monomer | 93.94 | 1×WMB; | |||
| Crystal Structure of human FABP4 in complex with 6-[(4-methoxyphenyl)methyl]-2H-1,2,4-triazine-3,5-… | monomer | 100 | 2×DMS; 1×U8H; 1×EDO; 2×SO4; | |||
| Crystal Structure of human FABP4 in complex with 1-(4-methylphenyl)sulfonyl-3-(8-tricyclo[5.2.1.02,… | monomer | 100 | 1×WNW; 2×SO4; 1×FMT; | |||
| Crystal Structure of human FABP4 in complex with 2-[(3-ethoxycarbonylthiophen-2-yl)carbamoyl]cyclop… | monomer | 100 | 1×WPQ; 1×FMT; 2×SO4; | |||
| Crystal Structure of human FABP4 in complex with 6-benzyl-2H-1,2,4-triazine-3,5-dithione | monomer | 100 | 1×VVL; 1×EDO; 2×SO4; | |||
| Crystal Structure of human FABP4 in complex with 2,6-dichloro-4-(1,1,1,3,3,3-hexafluoro-2-hydroxypr… | monomer | 100 | 1×WJ3; 1×DMS; 2×SO4; | |||
| Crystal Structure of human FABP4 in complex with 1-[(2-chlorophenyl)methyl]pyrrole-2-carboxamide | monomer | 100 | 1×76Y; 2×SO4; 1×FMT; | |||
| Crystal Structure of human FABP4 in complex with 2-[(3-methoxyphenyl)sulfanylmethyl]-1,3-thiazole-4… | monomer | 100 | 1×WQC; 2×SO4; 1×FMT; | |||
| Crystal Structure of human FABP4 in complex with 2-[(2-chlorophenoxy)methyl]-1,3-thiazole-4-carboxy… | monomer | 100 | 1×R9O; 2×SO4; 1×FMT; | |||
| Crystal Structure of human FABP4 in complex with N-methyl-6-(3-methylthiophen-2-yl)-4-phenyl-N-prop… | monomer | 100 | 1×WER; 1×SO4; 1×DMS; | |||
| Crystal Structure of human FABP4 in complex with 5-(4-chlorophenyl)-9-methyl-3-oxa-4-azatricyclo[5.… | monomer | 100 | 1×W9Q; 1×EDO; 2×SO4; | |||
| Crystal Structure of human FABP4 in complex with 6-(1,3-benzodioxol-5-ylmethyl)-3-sulfanyl-1,2,4-tr… | monomer | 100 | 1×WON; 2×SO4; 1×FMT; | |||
| Crystal Structure of human FABP4 in complex with 2-[rac-(9R,10S)-10-benzyl-3,3-dimethyl-1,5-dioxasp… | monomer | 100 | 1×TQO; 2×SO4; 1×FMT; | |||
| Crystal Structure of human FABP4 in complex with 3-[(E)-anilino-(2-oxo-1H-indol-3-ylidene)methyl]su… | monomer | 100 | 1×WDE; 2×SO4; 1×FMT; | |||
| Crystal Structure of human FABP4 in complex with 4-oxo-3-(2-phenylethyl)-10-oxa-3-azatricyclo[5.2.1… | monomer | 100 | 1×WH3; 1×FMT; | |||
| Crystal Structure of human FABP4 in complex with 2-(3-chloro-2-methylanilino)benzoic acid | monomer | 100 | 1×TLF; 2×SO4; | |||
| Crystal Structure of human FABP4 in complex with 2-(2-methoxyanilino)benzoic acid | monomer | 100 | 1×WM5; 2×SO4; 1×DMS; 1×FMT; | |||
| Crystal Structure of human FABP4 in complex with 2-[(3-chlorophenyl)methyl]-1,3-thiazole-4-carboxyl… | monomer | 100 | 1×IWI; 2×SO4; 1×FMT; | |||
| Crystal Structure of human FABP4 in complex with 2-[(3-ethoxycarbonyl-4,5,6,7-tetrahydro-1-benzothi… | monomer | 100 | 1×L8T; 3×SO4; | |||
| Crystal Structure of human FABP4 in complex with 2-(fluoren-9-ylidenemethyl)-4-hydroxy-2,3-dihydrop… | monomer | 100 | 1×Q0O; 2×SO4; | |||
| Crystal Structure of human FABP4 in complex with 2,3-bis(phenylmethoxy)benzoic acid | monomer | 100 | 1×WLB; 1×SO4; | |||
| Crystal Structure of human FABP4 in complex with 4-[3-(4-chlorophenyl)-1,2,4-oxadiazol-5-yl]butanoi… | monomer | 100 | 1×WL6; 2×FMT; 2×SO4; | |||
| Crystal Structure of human FABP4 in complex with 3-[(4-phenyl-5-sulfanylidene-1,3,4-thiadiazol-2-yl… | monomer | 100 | 1×WL0; 2×SO4; 1×EDO; 1×FMT; | |||
| Crystal Structure of human FABP4 in complex with 3-[(2-sulfanylphenyl)carbamoyl]bicyclo[2.2.1]hepta… | monomer | 100 | 1×DMS; 2×SO4; 1×WQ8; 1×FMT; | |||
| Crystal Structure of human FABP4 in complex with 2-[(2S)-oxolan-2-yl]-4-phenyl-3-(1H-tetrazol-5-yl)… | monomer | 100 | 1×SUX; 3×FMT; 2×DMS; 2×SO4; | |||
| Crystal Structure of human FABP4 in complex with 2-[(2R)-oxolan-2-yl]-4-phenyl-3-(1H-tetrazol-5-yl)… | monomer | 100 | 1×RI4; 4×FMT; 2×DMS; 2×SO4; | |||
| Crystal Structure of human FABP4 in complex with rac-(1R,2S)-2-[(3,4-dichlorophenoxy)methyl]cyclohe… | monomer | 100 | 2×SO4; 1×Q29; 2×FMT; | |||
| Crystal Structure of human FABP4 in complex with 3-(4-chlorophenyl)-4,5,6,6a-tetrahydro-3aH-cyclope… | monomer | 100 | 1×WFC; 2×SO4; 1×FMT; 1×WFK; | |||
| Crystal Structure of human FABP4 in complex with 2-tert-butyl-6-ethyl-4,5-diphenyl-3-(1H-tetrazol-5… | monomer | 100 | 2×SO4; 1×EOH; 1×WBR; | |||
| Crystal Structure of human FABP4 in complex with 4-(4-fluorophenyl)-2-piperidin-1-yl-3-(1H-tetrazol… | monomer | 100 | 1×VS5; 2×SO4; 1×FMT; 1×EDO; | |||
| Crystal Structure of human FABP4 in complex with 3-hydroxy-4-[3-(3-methoxyphenyl)propyl]-2-(2-pheny… | monomer | 100 | 1×OT9; 1×SO4; | |||
| Crystal Structure of human FABP4 in complex with 2-(2-hydroxy-3,5,5,8,8-pentamethyl-3,4,4a,6,7,8a-h… | monomer | 100 | 1×WO0; 1×SO4; 1×FMT; 1×GOL; | |||
| Crystal Structure of human FABP4 in complex with 7-methoxy-1-(3-methoxyphenyl)naphthalene-2-carboxy… | monomer | 100 | 2×WIL; 1×SO4; 1×FMT; 1×PG4; 1×EDO; | |||
| Crystal Structure of human FABP4 in complex with 5-benzyl-4-(2,5-dimethylpyrrol-1-yl)-1,2,4-triazol… | monomer | 100 | 1×FMT; 2×SO4; 1×S8X; | |||
| Crystal Structure of human FABP4 in complex with 4-methoxy-1,2-benzoxazol-3-amine | monomer | 100 | 1×5WX; 2×SO4; 1×UNU; 1×DMS; | |||
| Crystal Structure of human FABP4 in complex with 4-hexylsulfanyl-1-(3-pyridylmethyl)-6-sulfanyl-1,3… | monomer | 100 | 1×UO3; 2×SO4; 2×FMT; | |||
| Crystal Structure of human FABP4 in complex with 1-[(4-chlorophenyl)methyl]-3,4-dihydroxy-2H-pyrrol… | monomer | 100 | 2×SO4; 1×S4I; | |||
| Crystal Structure of human FABP4 in complex with 5-[(2-chloroanilino)methyl]-4-ethyl-1,2,4-triazole… | monomer | 100 | 1×FMT; 2×SO4; 1×QG0; | |||
| Crystal Structure of human FABP4 in complex with 5-[2-(1H-tetrazol-5-yl)ethyl]-6,7,8,9,10,11-hexahy… | monomer | 100 | 1×WN0; 2×SO4; 1×FMT; | |||
| Crystal Structure of human FABP4 in complex with 6-chloro-4-[(2-chlorophenyl)methyl]-2-methylquinol… | monomer | 100 | 1×WHR; 2×SO4; | |||
| Crystal Structure of human FABP4 in complex with 2-[2-(3-chlorophenyl)ethyl]-1,3-thiazole-4-carboxy… | monomer | 100 | 1×IQH; 1×FMT; 2×SO4; | |||
| Crystal Structure of human FABP4 in complex with 2-(9-benzyl-6-methyl-1,2,3,4-tetrahydrocarbazol-1-… | monomer | 100 | 1×R9C; 2×SO4; | |||
| Crystal Structure of human FABP4 in complex with 2-[(3-chlorophenoxy)methyl]-4-phenoxycyclohexane-1… | monomer | 100 | 1×KLX; 1×SO4; | |||
| Crystal Structure of human FABP4 in complex with 8-(3-bromophenyl)-7,9-dioxa-1-thia-3-azaspiro[4.5]… | monomer | 100 | 1×WJQ; 2×SO4; 1×DMS; 1×FMT; | |||
| Crystal Structure of human FABP4 in complex with (Z)-4-(4-bromo-2-chloroanilino)-4-oxobut-2-enoic a… | monomer | 100 | 2×SO4; 1×TB3; 1×CL; 1×DMS; | |||
| Crystal Structure of human FABP4 in complex with 5-(3,4-dichlorophenyl)-5-methyl-2-sulfanylidene-1,… | monomer | 100 | 1×W9F; 2×SO4; 1×FMT; | |||
| Crystal Structure of human FABP4 in complex with 7-(4-methoxyphenyl)-1,8-dithia-3-azaspiro[4.5]dec-… | monomer | 100 | 1×W9K; 2×SO4; 1×DMS; | |||
| Crystal Structure of human FABP4 in complex with rac-(1R,2S,4R)-2-[(3-chlorobenzoyl)amino]-4-phenox… | monomer | 100 | 1×DMS; 2×SO4; 1×VIY; 1×FMT; | |||
| Crystal Structure of human FABP4 in complex with (3-bromophenyl)-[(2Z)-2-phenylimino-1,3-thiazepan-… | monomer | 100 | 1×Q6I; 1×FMT; 2×SO4; | |||
| Crystal Structure of human FABP4 in complex with 4-(1-methyl-2-phenylindol-3-yl)cyclohexane-1-carbo… | monomer | 100 | 1×IUT; | |||
| Crystal Structure of human FABP4 in complex with N,N-diethyl-4-pyridin-4-yl-3-(1H-tetrazol-5-yl)-6,… | monomer | 100 | 1×QJX; 2×SO4; | |||
| Crystal Structure of human FABP4 in complex with 2-(1H-indol-7-yloxymethyl)-1,3-thiazole-4-carboxyl… | monomer | 100 | 1×WMQ; 1×EDO; 2×SO4; | |||
| Crystal Structure of human FABP4 in complex with N-(2,4-dichlorophenyl)-2-(2,6-dihydroxypyrimidin-4… | monomer | 100 | 2×SO4; 1×WGW; | |||
| Crystal Structure of human FABP4 in complex with 2-(indole-1-carbonylamino)benzoic acid | monomer | 100 | 1×NC0; 2×SO4; 1×DMS; | |||
| Crystal Structure of human FABP4 in complex with 2-tert-butylsulfanyl-6-phenyl-1H-1,3,5-triazine-4-… | monomer | 100 | 1×WKR; 1×FMT; 2×SO4; | |||
| Crystal Structure of human FABP4 in complex with 3-(4-chlorophenyl)sulfanylbutanoic acid | monomer | 100 | 1×MF9; 2×SO4; 1×FMT; | |||
| Crystal Structure of human FABP4 in complex with 2-[(3-chloro-4-fluorophenyl)carbamoyl]cyclohexane-… | monomer | 100 | 1×KWX; 2×SO4; | |||
| Crystal Structure of human FABP4 in complex with rac-(1R,2S)-2-[[3-(trifluoromethyl)phenoxy]methyl]… | monomer | 100 | 1×WLR; 1×DMS; 1×FMT; 2×SO4; | |||
| Human adipocyte lipid-binding protein FABP4 in complex with 3-(4-methoxy-3-methylphenyl) propionic … | monomer | 100 | 1×ZGB; | |||
| Crystal Structure of human FABP4 in complex with (2S)-6-(4-chlorophenoxy)-2-(4-methylphenoxy)hexano… | monomer | 100 | 1×WIC; 2×SO4; 1×FMT; | |||
| Crystal Structure of human FABP4 in complex with 2-[[2-(3-cyclopropyl-1,2,4-oxadiazol-5-yl)phenyl]c… | monomer | 100 | 2×DMS; 1×WG3; 2×SO4; | |||
| Crystal Structure of human FABP4 in complex with 6-(4-chlorophenyl)sulfanyl-2-(4-methylphenyl)sulfa… | monomer | 100 | 1×W8H; 2×SO4; | |||
| Crystal Structure of human FABP4 in complex with N-(2,1,3-benzothiadiazol-4-yl)-2,5-dichlorothiophe… | monomer | 100 | 1×TZJ; 2×SO4; 1×FMT; | |||
| Crystal Structure of human FABP4 in complex with 5-phenoxy-6-(2,2,2-trifluoroethoxy)-2-(trifluorome… | monomer | 100 | 2×SO4; 7×DMS; 1×TXO; | |||
| Crystal Structure of human FABP4 in complex with 5-[(4-chloroanilino)methyl]-2-phenyl-4H-[1,2,4]tri… | monomer | 100 | 1×LE5; 2×SO4; 1×FMT; | |||
| Human adipocyte lipid-binding protein FABP4 in complex with 3-(4-methoxyphenyl) propionic acid | monomer | 100 | 1×ZGC; | |||
| Crystal Structure of human FABP4 in complex with rac-(1R,2S)-2-[(3-methylphenoxy)methyl]cyclohexane… | monomer | 100 | 1×WNF; 1×DMS; 1×FMT; 1×SO4; | |||
| Crystal Structure of human FABP4 in complex with 2-[5-methyl-2-(1-methylcyclohexyl)-1,3-oxazol-4-yl… | monomer | 100 | 1×WEN; 1×FMT; 2×SO4; | |||
| Crystal Structure of human FABP4 in complex with (1S,2R)-2-[(5-carbamoyl-3-ethoxycarbonyl-4-methyl-… | monomer | 100 | 1×IOV; | |||
| Human adipocyte lipid-binding protein FABP4, Apo form at 1.08 Ang resolution. | monomer | 100 | ||||
| Crystal Structure of human FABP4 in complex with (2R)-1-[(2-phenylphenyl)carbamoyl]pyrrolidine-2-ca… | monomer | 100 | 2×SO4; 1×VJ3; | |||
| Crystal Structure of human FABP4 in complex with 2-[3-(4-chloro-2-phenoxyphenyl)phenyl]acetic acid | monomer | 100 | 2×SO4; 1×WKI; | |||
| Crystal Structure of human FABP4 in complex with 5-cyclohexyl-6-(2,2,2-trifluoroethoxy)-2-(trifluor… | monomer | 100 | 2×SO4; 1×MQF; 1×FMT; 4×DMS; | |||
| Crystal Structure of human FABP4 in complex with 7-(4-chlorophenyl)-1,2,3,4-tetrahydronaphthalene-1… | monomer | 100 | 1×KL3; 1×SO4; | |||
| Crystal Structure of human FABP4 in complex with 3-(3,4-dichlorophenyl)-3,7a-dihydro-1H-imidazo[1,5… | monomer | 100 | 2×SO4; 1×WPU; 1×FMT; | |||
| Crystal Structure of human FABP4 in complex with rac-(1R,2S)-2-(phenoxymethyl)cyclohexane-1-carboxy… | monomer | 100 | 1×WEA; 1×DMS; 2×SO4; | |||
| Crystal Structure of human FABP4 in complex with 2-(6-methyl-4-oxo-5-phenylthieno[2,3-d]pyrimidin-3… | monomer | 100 | 1×WFO; 2×SO4; | |||
| Crystal Structure of human FABP4 in complex with 4-(4-chlorophenoxy)benzenesulfinic acid:sodium hyd… | monomer | 100 | 1×WDO; 2×FMT; 2×SO4; | |||
| Crystal Structure of human FABP4 covalently modified with 1,2-benzothiazol-3-one | monomer | 100 | 2×PV6; 1×SO4; | |||
| Crystal Structure of human FABP4 in complex with 6-methyl-3-phenyl-1,2,4-triazin-5-ol | monomer | 100 | 1×WPZ; 2×SO4; | |||
| Crystal Structure of human FABP4 in complex with 2-(3-cyanoanilino)benzoic acid | monomer | 100 | 1×QX0; 2×SO4; 1×FMT; 1×DMS; | |||
| Crystal Structure of human FABP4 in complex with 6-bromo-3-hexyl-2-oxo-3,4-dihydro-1H-quinoline-4-c… | monomer | 100 | 1×WML; 2×SO4; 1×BR; | |||
| Crystal Structure of human FABP4 in complex with 2-[[3-(3-cyclopropyl-1,2,4-oxadiazol-5-yl)-4,5-dim… | monomer | 100 | 1×WKW; 1×SO4; | |||
| Crystal Structure of human FABP4 in complex with 2-chloro-4,6-bis(trifluoromethylsulfanyl)phenol | monomer | 100 | 1×FMT; 1×SO4; 1×RG6; 1×CL; | |||
| FABP4_3 in complex with 6,8-Dichloro-4-phenyl-2-piperidin-1-yl-quinoline-3-carboxylic acid | monomer | 93.94 | 1×65Z; 4×DMS; | |||
| Crystal Structure of human FABP4 in complex with 5-[(4-chlorophenoxy)methyl]-4-prop-2-enyl-1,2,4-tr… | monomer | 100 | 1×KCV; 2×SO4; 2×DMS; | |||
| Crystal Structure of human FABP4 in complex with 5-(4-chlorophenyl)-2-(hydroxymethylene)cyclohexane… | monomer | 100 | 1×M69; 1×SO4; | |||
| Crystal Structure of human FABP4 in complex with 5-(6-chloro-4-phenyl-2-piperidin-1-ylquinolin-3-yl… | monomer | 100 | 1×WJU; 2×SO4; | |||
| Crystal Structure of human FABP4 in complex with 2-[(3S)-oxolan-3-yl]oxy-4-phenyl-3-(1H-tetrazol-5-… | monomer | 100 | 1×WN5; 3×SO4; 4×DMS; | |||
| Crystal Structure of human FABP4 in complex with 6-[(3-methoxycarbonyl-4-thiophen-2-ylthiophen-2-yl… | monomer | 100 | 3×SO4; 1×WK9; | |||
| Crystal Structure of human FABP4 in complex with 3-[5-(3,5-dichlorophenyl)tetrazol-2-yl]propanoic a… | monomer | 100 | 1×N1I; 2×SO4; 1×FMT; | |||
| Crystal Structure of human FABP4 in complex with (1S,2S)-2-[(1R,2S,5R)-5-methyl-2-propan-2-ylcycloh… | monomer | 100 | 1×W95; 2×SO4; | |||
| Crystal Structure of human FABP4 in complex with 4-hydroxy-6-(2-naphthalen-1-ylethyl)pyran-2-one | monomer | 100 | 1×FMT; 2×SO4; 1×WHN; | |||
| Crystal Structure of human FABP4 in complex with 3-[(3,4-dichlorophenyl)methylsulfanyl]-1,2,4-triaz… | monomer | 100 | 1×P6X; 1×SO4; | |||
| Crystal Structure of human FABP4 in complex with 6-[(4-chlorophenyl)methylsulfanylmethyl]-2-sulfany… | monomer | 100 | 1×WHI; 1×FMT; 2×SO4; | |||
| Crystal Structure of human FABP4 in complex with 5-(3-bromo-4-methylphenyl)-3,3-dimethyl-5-oxopenta… | monomer | 100 | 1×W8N; 1×SO4; 1×FMT; | |||
| Crystal Structure of human FABP4 in complex with 2-cyclohexyl-6-hydroxy-1-benzofuran-3-one | monomer | 100 | 1×OM6; 2×SO4; 1×FMT; | |||
| Crystal Structure of human FABP4 in complex with 2-(5,6,7,8,9,10-hexahydrobenzo[8]annulen-3-yl)acet… | monomer | 100 | 1×TK6; 2×SO4; 1×FMT; | |||
| Crystal Structure of human FABP4 in complex with 2-(3,5-ditert-butyl-2-hydroxyphenyl)-3,3,3-trifluo… | monomer | 100 | 1×W9B; 2×SO4; 1×FMT; | |||
| Crystal Structure of human FABP4 in complex with 2-methyl-2-(2,3,4,5,6-pentachlorophenoxy)propanoic… | monomer | 100 | 1×FMT; 1×SO4; 1×QZI; | |||
| Crystal Structure of human FABP4 in complex with 5-[2-(2,4-dichlorophenoxy)phenyl]-1H-tetrazole | monomer | 100 | 1×LM9; 2×SO4; | |||
| Crystal Structure of human FABP4 in complex with 2-[(3-chloro-5,6-dihydrobenzo[b][1]benzothiepin-6-… | monomer | 100 | 1×QBX; 2×SO4; | |||
| Crystal Structure of human FABP4 in complex with 6-phenyl-11H-pyrimido[4,5-c][2]benzazepin-3-amine | monomer | 100 | 1×VI0; 2×SO4; 1×FMT; | |||
| Crystal Structure of human FABP4 in complex with 2-(3,5-ditert-butyl-2-hydroxyphenyl)-3,3,3-trifluo… | monomer | 100 | 1×FMT; 2×SO4; 1×W9B; | |||
| Crystal Structure of human FABP4 binding site mutated to that of FABP3 in complex with myristate | monomer | 93.94 | 1×MYR; | |||
| Crystal Structure of human FABP4 in complex with 5-phenylmethoxy-4-prop-2-enyl-1,2,4-triazole-3-thi… | monomer | 100 | 1×W8C; 2×SO4; 1×FMT; | |||
| Crystal Structure of delipidated apo human FABP4 | monomer | 100 | 1×EDO; 2×SO4; | |||
| Crystal Structure of human FABP4 in complex with [3-oxo-5-[4-(trifluoromethyl)phenyl]cyclohexen-1-y… | monomer | 100 | 1×WDI; 2×SO4; 1×DMS; 1×FMT; | |||
| Crystal Structure of human FABP4 in complex with 2-chloro-5-pyrrol-1-ylbenzoic acid | monomer | 100 | 1×UOR; 2×SO4; | |||
| Crystal Structure of human FABP4 in complex with 5-(3,5-dichloroanilino)-3,3-dimethyl-5-oxopentanoi… | monomer | 100 | 1×W90; 2×SO4; 1×FMT; | |||
| Crystal Structure of human FABP4 in complex with 4-(4-chloro-3-fluorophenoxy)-2-(3,4-dichlorophenyl… | monomer | 100 | 1×FMT; 2×SO4; 1×WMW; | |||
| Crystal Structure of human FABP4 in complex with 2-[2-[(2-chlorophenyl)methyl]-1-hydroxycyclohexyl]… | monomer | 100 | 1×WED; 2×SO4; | |||
| Crystal Structure of human FABP4 in complex with 5-[(4-chloro-3-phenoxyphenyl)methyl]-1H-tetrazole | monomer | 100 | 1×WQH; 2×SO4; | |||
| Crystal Structure of human FABP4 in complex with 5,7-bis(trifluoromethylsulfanyl)quinolin-8-ol | monomer | 100 | 1×WA4; 1×SO4; 1×FMT; | |||
| Crystal Structure of human FABP4 in complex with 6-[(3,4-dichlorophenyl)methyl]-5-methyl-1,1-dioxo-… | monomer | 100 | 2×SO4; 1×R80; | |||
| Crystal Structure of human FABP4 in complex with 5-ethyl-6-(3-methoxyphenyl)-3-methyl-2-sulfanylide… | monomer | 100 | 1×DMS; 2×SO4; 1×WNL; 1×FMT; | |||
| Crystal Structure of human FABP4 in complex with 5-[(2-chlorophenoxy)methyl]-4-propan-2-yl-1,2,4-tr… | monomer | 100 | 1×WF6; 2×SO4; | |||
| Crystal Structure of human FABP4 in complex with (E)-6-(5-methoxy-3,6,7-trimethyl-1,2-benzoxazol-4-… | monomer | 100 | 1×IZ7; 2×SO4; 1×FMT; | |||
| Crystal Structure of human FABP4 in complex with 4-[3-(trifluoromethyl)-5,6,7,8-tetrahydro-4H-cyclo… | monomer | 100 | 1×FMT; 1×SO4; 1×QD3; | |||
| Crystal Structure of human FABP4 in complex with 3-(3-chlorophenyl)-4-prop-2-enyl-1H-1,2,4-triazole… | monomer | 100 | 1×WGQ; 1×SO4; 1×FMT; | |||
| Crystal Structure of human FABP4 in complex with 5-[(3,4-dichlorophenyl)methyl]-1,1-dioxo-1,2,5-thi… | monomer | 100 | 1×O6Q; 3×SO4; | |||
| Crystal Structure of human FABP4 in complex with 1-[(4-methoxyphenyl)methyl]-5-propan-2-yl-5-prop-2… | monomer | 100 | 1×WQL; 2×SO4; 1×FMT; 1×EDO; | |||
| Crystal Structure of human FABP4 in complex with sulfate | monomer | 100 | 2×SO4; 1×DMS; | |||
| Crystal Structure of human FABP4 in complex with (1S,2S,5R)-3-(2-thiophen-3-ylacetyl)-3-azabicyclo[… | monomer | 100 | 1×WHB; 2×SO4; | |||
| Crystal Structure of human FABP4 in complex with 3-(5-methyl-2,3-diphenylindol-1-yl)propanoic acid | monomer | 100 | 2×SO4; 1×OKF; | |||
| Crystal Structure of human FABP4 in complex with 4-chloro-2,5-dimethyl-N-(2-methylpyrazol-3-yl)benz… | monomer | 100 | 1×WP8; 2×SO4; 1×FMT; | |||
| Crystal Structure of human FABP4 in complex with 5-[(3-chlorophenyl)methyl]-6-hydroxy-1-methyl-4-mo… | monomer | 100 | 1×FMT; 1×WLN; 2×SO4; | |||
| Crystal Structure of human FABP4 in complex with 4-(2-methylpropyl)-2-phenyl-3-(1H-tetrazol-5-yl)-6… | monomer | 100 | 1×DMS; 1×SO4; 1×QN6; 1×FMT; | |||
| Crystal Structure of human FABP4 in complex with 3-[(2,4-dichloro-5-methylphenyl)sulfonylamino]thio… | monomer | 100 | 1×WIF; 2×SO4; 1×FMT; | |||
| Crystal Structure of human FABP4 in complex with 3-[1-(4-carbamoylphenyl)-5-(4-fluorophenyl)pyrrol-… | monomer | 100 | 1×M8I; 2×SO4; | |||
| Crystal Structure of human FABP4 in complex with 4-[[3-(3-cyclopropyl-1,2,4-oxadiazol-5-yl)-6,6-dif… | monomer | 100 | 2×SO4; 1×FMT; 1×WFX; 1×DMS; 1×CL; | |||
| Crystal Structure of human FABP4 in complex with 4-(4-fluorophenyl)sulfanyl-6-methyl-2-phenylpyrimi… | monomer | 100 | 1×WOI; 2×SO4; 1×FMT; 1×DMS; | |||
| Crystal Structure of human FABP4 in complex with 4-hydroxy-2-[(E)-2-(2-phenylcyclohexyl)ethenyl]-2,… | monomer | 100 | 1×FMT; 1×SO4; 1×IKQ; 1×CL; | |||
| Crystal Structure of human FABP4 in complex with 5-[[3-(3-cyclopropyl-1,2,4-oxadiazol-5-yl)-6,6-dif… | monomer | 100 | 2×SO4; 1×FMT; 1×Q4X; 1×DMS; 1×CL; | |||
| Crystal Structure of human FABP4 in complex with 2,5,5-trimethyl-6,7,8,9-tetrahydrobenzo[7]annulene… | monomer | 100 | 1×V4R; 2×SO4; 1×FMT; | |||
| Crystal Structure of human FABP4 in complex with 3-methyl-2-(2,4,5-trichlorophenyl)sulfanylbutanoic… | monomer | 100 | 3×K0U; 2×SO4; 1×FMT; | |||
| Crystal Structure of human FABP4 in complex with 2,4,6-triisopropylbenzenesulfonic acid | monomer | 100 | 1×FMT; 1×SO4; 1×75D; 1×CL; | |||
| Crystal Structure of human FABP4 in complex with 6-bromo-4-hexyl-2-oxo-1,3-dihydroquinoline-4-carbo… | monomer | 100 | 1×QYP; 2×SO4; | |||
| Crystal Structure of human FABP4 in complex with 1-[(4-chloro-3-phenoxyphenyl)methyl]-4-hydroxypyri… | monomer | 100 | 2×SO4; 1×MWR; | |||
| Crystal Structure of human FABP4 in complex with (4-chlorophenyl)methyl 5-fluoro-2,4-dioxo-1H-pyrim… | monomer | 100 | 1×UKN; 2×SO4; | |||
| Crystal Structure of human FABP4 in complex with 2-[2,3-bis[(2-chlorophenyl)methoxy]phenyl]-2-metho… | monomer | 100 | 2×SO4; 1×WA9; | |||
| Crystal Structure of human FABP4 in complex with (2R)-1-[(3,5-dichloro-2-phenylphenyl)carbamoyl]pyr… | monomer | 100 | 2×SO4; 1×UOF; 1×FMT; | |||
| Crystal Structure of human FABP4 in complex with 5-[(4-chlorophenyl)sulfanylmethyl]-2-methylpyrazol… | monomer | 100 | 2×SO4; 1×W7U; | |||
| Crystal Structure of human FABP4 in complex with 2-[[5-chloro-2-(3-methyl-1,2,4-oxadiazol-5-yl)phen… | monomer | 100 | 2×SO4; 4×DMS; 1×WQ3; | |||
| Human adipocyte lipid-binding protein FABP4 in complex with (S)-ibuprofen | monomer | 100 | 1×IBP; | |||
| Crystal Structure of human FABP4 with active site mutated to that of FABP3 in complex with palmitate | monomer | 93.94 | 1×PLM; | |||
| Crystal Structure of human FABP4 binding site mutated to that of FABP3 in complex with 6-chloro-2-m… | monomer | 93.94 | 1×DMS; 1×5M8; 2×SO4; | |||
| Crystal Structure of human FABP4 binding site mutated to that of FABP3 in complex with 1-[(4-chloro… | monomer | 93.94 | 1×O9U; 1×DMS; | |||
| Crystal Structure of human FABP4 in complex with 2-benzyl-6-tert-butyl-3-methyl-4-phenyl-5-(1H-tetr… | monomer | 100 | 2×SO4; 1×UUX; | |||
| Crystal Structure of human FABP4 in complex with 6-chloro-4-phenyl-2-piperidin-1-yl-3-(1H-tetrazol-… | monomer | 100 | 1×65X; 1×SO4; 1×DMS; 2×TRS; | |||
| Crystal Structure of human FABP4 in complex with 2-[1-[(3-chlorophenyl)methyl]indol-2-yl]cyclopropa… | monomer | 100 | 1×WNB; | |||
| Crystal Structure of human FABP4 in complex with 5,6-dichloro-3-(2-chlorophenyl)-1H-indole-2-carbox… | monomer | 100 | 1×UB8; 2×SO4; 1×FMT; 1×DMS; | |||
| Crystal Structure of human FABP4 in complex with 3-[(4-methyl-3-phenoxyphenyl)methyl]-1H-pyrazol-5-… | monomer | 100 | 1×WKN; 2×SO4; 1×FMT; | |||
| human fatty acid binding protein 4 in complex with 6-Chloro-2-methyl-4-phenyl-quinoline-3-carboxyli… | monomer | 100 | 1×5M8; | |||
| Crystal Structure of human FABP4 in complex with 5-cyclohexyl-2-hydroxybenzoic acid | monomer | 100 | 1×KWB; 2×SO4; | |||
| Crystal Structure of human FABP4 in complex with 6-cyclopentyl-N,5-dimethyl-4-phenyl-N-propan-2-yl-… | monomer | 100 | 2×SO4; 1×Q1I; 2×DMS; 1×FMT; | |||
| Crystal Structure of human FABP4 binding site mutated to that of FABP3 in complex with 6-chloro-4-(… | monomer | 93.94 | 1×P5Z; 1×DMS; 1×SO4; | |||
| Human adipocyte lipid-binding protein FABP4 in complex with (S)-3-phenyl butyric acid | monomer | 100 | 1×FBZ; | |||
| Human adipocyte lipid-binding protein FABP4 in complex with (R)-ibuprofen | monomer | 100 | 1×IZP; | |||
| Crystal Structure of human FABP4 in complex with 3-[(2-phenylphenoxy)methyl]benzoic acid | monomer | 100 | 1×SO4; 1×WNR; | |||
| Crystal Structure of human FABP4 in complex with thieno[2,3-d]pyrimidine-2,4-diamine | monomer | 100 | 1×WEI; 2×SO4; | |||
| Crystal Structure of human FABP4 in complex with 3-cyclohexyl-2-ethylsulfanyl-6-hydroxypyrimidin-4-… | monomer | 100 | 2×WGL; 2×SO4; 1×FMT; | |||
| Crystal Structure of human FABP4 in complex with 1-[(4-chlorophenyl)methyl]-4-hydroxypyridin-2-one | monomer | 100 | 2×SO4; 1×VMN; | |||
| Human adipocyte lipid-binding protein FABP4 in complex with citric acid | monomer | 100 | 1×CIT; | |||
| Crystal Structure of human FABP4 in complex with rac-(2R)-1-[[3-(3-cyclopropyl-1,2,4-oxadiazol-5-yl… | monomer | 100.0 | 1×WE6; 2×SO4; | |||
| Crystal Structure of human FABP4 binding site mutated to that of FABP3 in complex with 1-[(4-chloro… | monomer | 93.94 | 2×SO4; 1×WMF; 1×DMS; | |||
| Crystal Structure of human FABP4 in complex with 5-(chloromethyl)-2-phenyl-4H-[1,2,4]triazolo[1,5-a… | monomer | 100 | 1×WJ8; 2×SO4; | |||
| Crystal Structure of human FABP4 in complex with 2-cyclopentyl-4-(4-fluorophenyl)-6-[1-(methoxymeth… | monomer | 100 | 2×SO4; 1×K7C; | |||
| Crystal Structure of human FABP4 in complex with 6-fluoro-1,3-benzothiazol-2-amine | monomer | 100 | 1×FBB; 1×SO4; | |||
| human FABP4 in complex with 6-Chloro-4-phenyl-2-piperidin-1-yl-quinoline-3-carboxylic acid at 1.29A | monomer | 100 | 1×5M7; 3×SO4; | |||
| Crystal Structure of human FABP4 binding site mutated to that of FABP3 in complex with 6-cyclopenty… | monomer | 93.94 | 1×Q1I; 2×SO4; 1×CL; | |||
| Crystal structure of human FABP4 in complex with a novel inhibitor | monomer | 100 | 1×EHO; 1×EDO; | |||
| Crystal Structure of human FABP4 in complex with 2-[(3-phenylthiophen-2-yl)carbamoyl]cyclopentene-1… | monomer | 100 | 1×SO4; 1×W9W; | |||
| Crystal structure of human FABP4 in complex with a novel inhibitor | monomer | 100 | 1×EHC; | |||
| Crystal Structure of human FABP4 soaked with glycerol | monomer | 100 | 2×GOL; 2×SO4; | |||
| Crystal structure of human FABP4 in complex with a novel inhibitor | monomer | 100 | 1×EH6; 1×EDO; | |||
| Crystal Structure of human FABP4 in complex with (2R,3S)-2-(phenoxymethyl)-1-phenyl-pyrrolidine-3-c… | monomer | 100 | 1×W8T; 2×SO4; 3×DMS; | |||
| Crystal structure of human FABP4 in complex with a novel inhibitor | monomer | 100 | 1×EHU; 1×EDO; | |||
| Crystal Structure of aP2 | monomer | 100 | 1×PO4; 1×PLM; 2×ACY; | |||
| Crystal Structure of human FABP4 in complex with rac-(1R,3S)-2,2-dimethyl-3-[(2-phenylphenyl)carbam… | monomer | 100 | 2×SO4; 1×RJM; 2×CL; | |||
| Crystal structure of FABP4 in complex with novel inhibitor | monomer | 100 | 1×76D; | |||
| Crystal structure of FABP4 in complex with novel inhibitor | monomer | 100 | 1×75D; | |||
| Crystal Structure of human FABP4 in complex with 5-(4-chlorophenyl)-6-(2,2,2-trifluoroethoxy)-2-(tr… | monomer | 100 | 1×WOB; 2×SO4; | |||
| Crystal structure of human FABP4 complexed with ligand 2-fluoro-5-((4-methoxynaphthalene)-1-sulfona… | monomer | 100 | 1×8JO; | |||
| Crystal structure of human FABP4 complexed with ligand 4-Fluoro-3-((4-methoxynaphthalene)-1-sulfona… | monomer | 100 | 1×8JL; | |||
| Crystal Structure of human FABP4 in complex with rac-(1R,2R)-2-[[3-(3-methyl-1,2,4-oxadiazol-5-yl)-… | monomer | 100 | 1×WP0; 1×SO4; | |||
| Crystal structure of human FABP4 complexed with ligand 2-fluoro-3-((4-methoxynaphthalene)-1-sulfona… | monomer | 100 | 1×8JR; | |||
| Crystal Structure of human FABP4 in complex with 4-[[3-(3-cyclopropyl-1,2,4-oxadiazol-5-yl)-4,5,6,7… | monomer | 100 | 1×WJH; 2×DMS; 1×FMT; 2×SO4; | |||
| Crystal Structure of FABP4 in complex with 3-(5-cyclopropyl-2,3-diphenyl-1H-indol-1-yl)propanoic ac… | monomer | 100 | 1×57P; | |||
| Crystal Structure of human FABP4 in complex with 1-[[4-chloro-2-(trifluoromethyl)phenyl]carbamoylam… | monomer | 100 | 1×WLF; 2×SO4; 1×FMT; 1×DMS; | |||
| Crystal structure of human FABP4 complexed with C3 | monomer | 100 | 1×W6K; 1×EDO; | |||
| Crystal Structure of FABP4 in complex with 3-(2-phenyl-1H-indol-1-yl)propanoic acid | monomer | 100 | 1×57Q; | |||
| Crystal Structure of FABP4 in complex with 3-[5-cyclopropyl-3-(3-methoxypyridin-4-yl)-2-phenyl-1H-i… | monomer | 100 | 1×L19; | |||
| Crystal structure of human FABP4 in complex with a novel inhibitor | monomer | 100 | 1×EHR; 1×EDO; | |||
| Crystal structure of human FABP4 complexed with ligand 5-((4-methoxynaphthalene)-1-sulfonamido)pent… | monomer | 100 | 1×8JX; | |||
| Crystal structure of human FABP4 complexed with ligand 5-((4-bromonaphthalene)-1-sulfonamido)pentan… | monomer | 100 | 1×8K0; | |||
| Crystal structure of human FABP4 in complex with a novel inhibitor | monomer | 99.24 | 1×EHO; | |||
| Crystal Structure of FABP4 in complex with 3-{5-cyclopropyl-3-(3,5-dimethyl-1H-pyrazol-4-yl)-2-[3-(… | monomer | 100 | 1×L96; 2×PO4; | |||
| Crystal structure of human FABP4 complexed with C7 | monomer | 100 | 1×W6B; | |||
| Human adipocyte lipid-binding protein FABP4 in complex with fluorescein | monomer | 100 | 2×FLU; | |||
| Crystal Structure of human FABP4 in complex with 2-[[3-(3-cyclopropyl-1,2,4-oxadiazol-5-yl)-4,5-dim… | monomer | 100 | 1×U6O; 1×FMT; 1×DMS; 2×SO4; | |||
| Crystal Structure of human FABP4 in complex with 1-[(2,4-dichlorophenyl)methyl]-4-hydroxy-3-[(E)-3-… | monomer | 100 | 2×SO4; 1×O1L; | |||
| Crystal Structure of human FABP4 in complex with 5-[(3-chloro-2-methylphenoxy)methyl]-2-phenyl-4H-[… | monomer | 100 | 2×SO4; 1×W7Z; | |||
| Crystal Structure of apo human FABP4, cubic form | monomer | 100 | 2×SO4; 1×K; | |||
| Crystal Structure of human FABP4 in complex with 2-(3-phenyl-4-piperidin-1-ylphenyl)acetic acid | monomer | 100 | 1×QJD; 2×SO4; | |||
| ammonium sulfate-based apo human FABP4, primitive orthorhombic form I | monomer | 100 | 2×SO4; | |||
| Crystal Structure of human FABP4 in complex with 5-[(3-chloro-2-methylphenoxy)methyl]-2-phenyl-4H-[… | monomer | 100 | 2×SO4; 1×W7Z; | |||
| Crystal Structure of Human Adipocyte Fatty Acid Binding Protein (FABP4) at 1.4 Ang. Resolution | monomer | 100 | ||||
| Crystal structure of human adipocyte fatty acid binding protein in complex with ((2'-(5-ethyl-3,4-d… | monomer | 100 | 2×SO4; 1×T4B; | |||
| Crystal structure of human adipocyte fatty acid binding protein in complex with a non-covalent liga… | monomer | 100 | 1×B1V; | |||
| Crystal structure of human adipocyte fatty acid binding protein in complex with a carboxylic acid l… | monomer | 100 | 1×CRZ; | |||
| N-Benzyl-indolo carboxylic acids: Design and synthesis of potent and selective adipocyte Fatty-Acid… | monomer | 100 | 1×F8A; | |||
| N-Benzyl-indolo carboxylic acids: Design and synthesis of potent and selective adipocyte Fatty-Acid… | monomer | 100 | 1×8CA; | |||
| N-Benzyl-indolo carboxylic acids: Design and synthesis of potent and selective adipocyte Fatty-Acid… | monomer | 100 | 1×I4A; | |||
| Crystal Structure of human FABP4 in complex with 6-(difluoromethyl)-4-isobutyl-5-methoxycarbonyl-2-… | monomer | 100 | 2×SO4; 1×WE2; 2×DMS; | |||
| Crystal Structure of human FABP4 with binding site mutated to FABP5 in complex with 5-methylsulfany… | monomer | 93.85 | 1×QLL; 1×DMS; 1×EDO; | |||
| Crystal Structure of human FABP4 binding site mutated to that of FABP5 in complex with myristic acid | monomer | 93.85 | 1×MYR; | |||
| Crystal Structure of human FABP4 binding site mutated to that of FABP5 | monomer | 93.85 | 2×DMS; 1×IZ7; | |||
| Crystal Structure of human FABP4 binding site mutated to that of FABP5 in complex with 2-[2,3-bis[(… | monomer | 93.85 | 1×WA9; | |||
| Crystal Structure of human FABP4 binding site mutated to that of FABP5 in complex with 4-[[3-(3-cyc… | monomer | 93.85 | 1×WJH; 2×DMS; 1×SO4; | |||
| Crystal Structure of human FABP4 binding site mutated to that of FABP5 in complex with 5-(3-bromo-4… | monomer | 93.85 | 1×W8N; 1×PG4; 1×DMS; | |||
| Crystal Structure of human FABP4 in complex with 2-[1-(methoxymethyl)cyclopentyl]-6-pentyl-4-phenyl… | monomer | 100 | 1×A1H4Y; 1×DMS; | |||
| Crystal Structure of human FABP4 in complex with 2-[2-(benzothiophen-3-yl)-2,3-dihydrobenzothiophen… | monomer | 100 | 2×SO4; 1×GFS; | |||
| Crystal Structure of human FABP4 in complex with 2-[[5-bromo-2-(3-cyclopropyl-1,2,4-oxadiazol-5-yl)… | monomer | 100 | 2×SO4; 3×DMS; 1×WI8; 1×BR; | |||
| Crystal Structure of human FABP4 binding site mutated to that of FABP5 in complex with 5-cyclohexyl… | monomer | 93.85 | 3×DMS; 1×MQF; | |||
| Crystal Structure of human FABP4 binding site mutated to that of FABP5 in complex with 5-phenoxy-6-… | monomer | 93.85 | 3×DMS; 1×TXO; | |||
| Crystal Structure of human FABP4 binding site mutated to that of FABP5 in complex with 2-(indole-1-… | monomer | 93.85 | 1×NC0; 1×EDO; 1×PG4; | |||
| Crystal Structure of human FABP4 binding site mutated to that of FABP5 in complex with rac-(1R,2S)-… | monomer | 93.85 | 1×WYO; 1×DMS; 1×SO4; | |||
| Crystal Structure of human FABP4 binding site mutated to that of FABP5 in complex with 6-chloro-5-f… | monomer | 93.85 | 1×WPK; 1×MYR; | |||
| Crystal Structure of human FABP4 binding site mutated to that of FABP5 in complex with 2-[[3-(3-cyc… | monomer | 93.85 | 2×DMS; 1×WKW; | |||
| Crystal Structure of human FABP4 binding site mutated to that of FABP5 in complex with 5-(3,5-dichl… | monomer | 93.85 | 1×W90; | |||
| Crystal Structure of human FABP4 binding site mutated to that of FABP5 in complex with 6-fluoro-1,3… | monomer | 93.85 | 1×FBB; 1×MYR; 1×SO4; | |||
| Crystal Structure of human FABP4 binding site mutated to that of FABP5 in complex with rac-(1R,2R)-… | monomer | 93.85 | 1×WOU; | |||
| Crystal Structure of human FABP4 binding site mutated to that of FABP5 in complex with rac-(1R,2S)-… | monomer | 93.85 | 1×WHZ; 1×DMS; 1×SO4; 1×PG4; | |||
| Crystal Structure of human FABP4 binding site mutated to that of FABP5 in complex with 6-cyclopenty… | monomer | 93.85 | 1×Q1I; 2×DMS; 1×SO4; | |||
| Crystal Structure of human FABP4 binding site mutated to that of FABP5 in complex with 2-[[6,6-difl… | monomer | 93.85 | 1×QJQ; | |||
| Crystal Structure of human FABP4 binding site mutated to that of FABP5 in complex with isoquinolin-… | monomer | 93.85 | 1×WLX; 1×MYR; | |||
| Crystal Structure of human FABP4 binding site mutated to that of FABP5 in complex with 2-benzyl-6-t… | monomer | 93.85 | 1×UUX; | |||
| Crystal Structure of human FABP4 binding site mutated to that of FABP5 in complex with N-methyl-6-(… | monomer | 93.85 | 1×WER; 2×DMS; | |||
| Crystal Structure of human FABP4 binding site mutated to that of FABP5 in complex with 2-cyclopenty… | monomer | 93.85 | 1×K7C; 1×DMS; | |||
| Crystal Structure of apo human FABP4, tetragonal form | monomer | 100 | 1×EDO; | |||
| FABP4 in complex with 6-Chloro-2-isopropyl-4-(3-isopropyl-phenyl)-quinoline-3-carboxylic acid | monomer | 100 | 1×65Y; | |||
| X-ray structure of the human adipocyte fatty acid-binding protein complexed with the fluorescent pr… | monomer | 100 | 1×8QU; | |||
2 SWISS-MODEL models
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 5edc.1.A | monomer | 0.86 | 1×5M7; | 100.00 | ||
| 4azm.1.A | monomer | 0.78 | 52.27 | |||